BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12791040)

  • 1. Gaucher's disease: identification of novel mutant alleles and genotype-phenotype relationships.
    Zhao H; Keddache M; Bailey L; Arnold G; Grabowski G
    Clin Genet; 2003 Jul; 64(1):57-64. PubMed ID: 12791040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher's disease.
    Tayebi N; Reissner KJ; Lau EK; Stubblefield BK; Klineburgess AC; Martin BM; Sidransky E
    Pediatr Res; 1998 May; 43(5):571-8. PubMed ID: 9585001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal lethal phenotype with generalized ichthyosis in a type 2 Gaucher disease patient with the [L444P;E326K]/P182L genotype: effect of the E326K change in neonatal and classic forms of the disease.
    Chabás A; Gort L; Díaz-Font A; Montfort M; Santamaría R; Cidrás M; Grinberg D; Vilageliu L
    Blood Cells Mol Dis; 2005; 35(2):253-8. PubMed ID: 15967693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-pseudogene-derived complex acid beta-glucosidase mutations causing mild type 1 and severe type 2 gaucher disease.
    Grace ME; Ashton-Prolla P; Pastores GM; Soni A; Desnick RJ
    J Clin Invest; 1999 Mar; 103(6):817-23. PubMed ID: 10079102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.
    Choy FY; Zhang W; Shi HP; Zay A; Campbell T; Tang N; Ferreira P
    Blood Cells Mol Dis; 2007; 38(3):287-93. PubMed ID: 17196853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.
    Stone DL; Tayebi N; Orvisky E; Stubblefield B; Madike V; Sidransky E
    Hum Mutat; 2000; 15(2):181-8. PubMed ID: 10649495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of 13 GBA mutant alleles identified in Gaucher disease patients: Pathogenic changes and "modifier" polymorphisms.
    Montfort M; Chabás A; Vilageliu L; Grinberg D
    Hum Mutat; 2004 Jun; 23(6):567-75. PubMed ID: 15146461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetics of Gaucher's disease. Genotype-phenotype correlation].
    Alfonso Palacín P; Pocoví M
    Med Clin (Barc); 2011 Sep; 137 Suppl 1():17-22. PubMed ID: 22230121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease.
    Tsuji S; Choudary PV; Martin BM; Stubblefield BK; Mayor JA; Barranger JA; Ginns EI
    N Engl J Med; 1987 Mar; 316(10):570-5. PubMed ID: 2880291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of severity of Gaucher's disease by identification of mutations at DNA level.
    Zimran A; Sorge J; Gross E; Kubitz M; West C; Beutler E
    Lancet; 1989 Aug; 2(8659):349-52. PubMed ID: 2569551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Distribution of mutations of acid beta-D-glucosidase gene (GBA) among 68 Russian patients with Gaucher's disease].
    Bukina TM; Tsvetkova IV
    Biomed Khim; 2007; 53(5):593-602. PubMed ID: 18078074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygous loss of a cysteine residue in the glucocerebrosidase gene results in Gaucher's disease with a hydropic phenotype.
    Church HJ; Cooper A; Stewart F; Thornton CM; Wraith JE
    Eur J Hum Genet; 2004 Nov; 12(11):975-8. PubMed ID: 15292921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gaucher disease: in vivo evidence for allele dose leading to neuronopathic and nonneuronopathic phenotypes.
    Zhao H; Bailey LA; Elsas LJ; Grinzaid KA; Grabowski GA
    Am J Med Genet A; 2003 Jan; 116A(1):52-6. PubMed ID: 12476451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of the frequencies of GBA gene major mutations in patients with Gaucher disease in Ukraine].
    Horovenko NH; Ol'khovych NV; Nedoboĭ AM; Pichkur NO
    Tsitol Genet; 2007; 41(4):41-7. PubMed ID: 18030725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genetic studies of Japanese homozygotes for the Gaucher disease L444P mutation.
    Ida H; Rennert OM; Iwasawa K; Kobayashi M; Eto Y
    Hum Genet; 1999; 105(1-2):120-6. PubMed ID: 10480365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis in 46 British and Irish patients with Gaucher's disease.
    Hatton CE; Cooper A; Whitehouse C; Wraith JE
    Arch Dis Child; 1997 Jul; 77(1):17-22. PubMed ID: 9279145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.
    Koprivica V; Stone DL; Park JK; Callahan M; Frisch A; Cohen IJ; Tayebi N; Sidransky E
    Am J Hum Genet; 2000 Jun; 66(6):1777-86. PubMed ID: 10796875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel frameshift mutation (Pro171fsX21) in neonatal type 2 Gaucher's disease.
    Park HW; Lee Y; Kim GH; Lee BS; Kim KS; Yoo HW; Kim EA
    Gene; 2012 Oct; 507(2):170-3. PubMed ID: 22772462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of a novel mutation c.1090G>T (G325W) and nine common mutant alleles leading to Gaucher disease in Spanish patients.
    Torralba MA; Pérez-Calvo JI; Pastores GM; Cenarro A; Giraldo P; Pocoví M
    Blood Cells Mol Dis; 2001; 27(2):489-95. PubMed ID: 11259172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of type 3 (neuronopathic) Gaucher disease in Thai patients.
    Suwannarat P; Keeratichamroen S; Wattanasirichaigoon D; Ngiwsara L; Cairns JR; Svasti J; Visudtibhan A; Pangkanon S
    Blood Cells Mol Dis; 2007; 39(3):348-52. PubMed ID: 17689991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.